Accelsiors' Strategic Consultancy and State-of-the-Art Facilities
Our Clinical Development consultancy services help deliver strategic assistance to biotech and pharmaceutical companies on how to successfully navigate bringing novel therapies to the market. Our expertise in early-phase research ensures we deliver for you tailored approaches, optimized study design, and robust feasibility assessments which ensure accelerating your program, all the while minimizing risks.
The Accelsiors State-of-the-Art Early-Phase Facilities guarantee high standards of care, efficient trial execution, as well as data accuracy. Our advanced monitoring and our patient-centric mentality and approach, alongside the facilities make us a perfect, trusted and reliable partner for your First-in-Human (FIH) trials and complex dose-escalation studies.
Ensuring Compliance in Clinical Trials
The very cornerstone of our services, regulatory and ethical compliance, is supported by Accelsiors Regulatory Unit. Our team guarantees adherence to local and international standards with a detailed and rigorous protocol design, persistent monitoring, as well as quality assurance processes. The Regulatory team’s collaborative approach with all regulatory authorities and ethics committees ensures the integrity of your clinical trials as well as the safety of participants. We help our clients streamline their clinical development journey with our scientific rigor, excellent operations, and our patient-centric approach. This way we ensure that promising therapies reach the market efficiently and ethically.
Whether you have questions, or want to explore partnership opportunities, get in touch!
